Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-21-012309)

Filing Details

Accession Number:: 0000899243-21-012309
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-17 20:00:12
Reporting Period:: 2021-03-15

Accepted Time:: 2021-03-17 20:00:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1403752	Zymeworks Inc.	ZYME	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1791978	Kathryn O'driscoll	C/O Zymeworks Inc. 1385 West 8Th Avenue, Suite 540 Vancouver A1 V6H 3V9	Chief People Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Disposition	2021-03-15	786	$34.72	5,003	No	4	S	Direct
Common Shares	Acquisiton	2021-03-15	837	$34.24	5,840	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	M	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Stock Option (Right to Buy)	Disposition	2021-03-15	837	$0.00	837	$34.24

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
94,160		2029-11-07	No	4	M	Direct

Footnotes

Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date of November 8, 2019, and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date.